Dentistry is having the most agitated market nowadays due to incessantly rising problems in oral hygiene. Several types of medications are used to treat various diseases of the oral cavity. The dental drug industry reported decline in revenue due to the recent world economic crisis; however, the industry witnessed relatively considerable growth. This is due to wide availability of specialties for each and every issue and its multiple application. If mentioned, there are around 10 different branches of Dentistry for a particular disease, these are Pediatrics Dentistry, Dental public health, Oral and maxillofacial pathology, Oral and maxillofacial radiology, Oral and maxillofacial surgery, Endodontics, Orthodontics, Periodontics & Prosthodontics.
The dental drugs market can be segmented based on drug type, mode of administration, and distribution channel. In terms of drug type, the market can be classified into analgesic, anesthetics, antibiotics, antifungals, antiseptics, fluorides, benzodiazepines, and saliva substitutes. Based on mode of administration, the dental drugs market can be categorized into injectable, oral, and spray. In terms of distribution channel, the market can be segmented into drug stores, retail pharmacies, hospital pharmacies, and online stores.
Rising incidence of dental caries and other periodontal diseases, increased endodontic cases, growing public awareness about oral hygiene and dental care, rise in geriatric population, and advancement in dental disease diagnostic and treatment technologies are the major factors driving the dental drugs market. Moreover, increasing disposable incomes in developing countries is a major factor boosting the dental drugs market. However, high cost and limited reimbursement available for the treatment, competitive pricing issue faced by key producers, and shortage of skilled dental professionals are the major restraints of the market. Contradictory to these factors are the rising opportunities in the dental drug with increased online purchases of oral hygiene product, the introduction of new technologies, more emphasis towards painless treatment, increasing number of dental clinics with huge investment and increased interest in female population towards this profession.
Triclosan/fluoride, a major breakthrough, completed the clinical trial and is being used in the treatment of gingival diseases. Usage of chlorhexidine rinse among low income older population to prevent tooth loss, periodontal disease, tooth decay is another healthy trend. In 2016, a new study was proposed for the use of Xylitol gum as a dietary supplement to maintain maternal oral health to reduce the rate of periodontal disease and caries, preterm birth prevalence, and neonatal mortality. Linaclotide, a potential drug for dental diseases, is currently in phase II clinical trial.
Geographically, the dental drugs market can be divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominated the global dental drugs market due to rising number of cases of dental caries and tooth ache among kids with an inclination toward junk foods and sweets. High awareness among working professionals and adults about oral hygiene is another factor propelling the market in the region. North America accounted for a substantially large share of the global dental drugs market, followed by Europe. Increased demand for dental drugs in developed countries in Europe such as the U.K., Germany, and France. Increasing demand for dental drugs in countries such as India, China, and Japan is expected to boost the market in Asia Pacific. However, affordability and lack of technology act as major restraints of the dental drugs market in underdeveloped regions such as Middle East & Africa and Latin America. The market in these regions is expected to grow driven by developing countries such as Brazil and South Africa.
Key players operating in the dental drugs market include Merck, Bayer, J&J, GSK, 3M, Sunstar, Colgate-Palmolive, DenMat, Danaher Corporation, Kavo Dental Gmbh, and Sirona Dental Systems Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.